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Abstract 
 
5-HT neurones in the median raphe nucleus (MRN) are involved in anxiety and the 
sleep/wake cycle.  Here, using in vitro electrophysiology, we examined if the firing of 
MRN 5-HT neurones is regulated by GABAA receptors.  The GABAA receptor 
agonists THIP and muscimol caused concentration dependent inhibition of MRN 
5-HT neurones.  The GABAA receptor antagonist bicuculline blocked the responses to 
THIP and muscimol.  Bicuculline alone increased the basal firing activity.  Responses 
to THIP were enhanced by the Z hypnotic zolpidem at concentrations selective for the 
α2/α3 subunits of the GABAA receptor (0.2 and 1 mM) but not at a concentration 
selective for the α1 subunit (0.02 mM).  Consistent with these functional data, 5-HT 
neurones have been shown to express the α3 (but not α2) subunit. The anxiolytic 
effects of GABAA receptor modulators are reportedly mediated by α3-containing 
receptors.  Hence the MRN 5-HT system may be a target for anxiolytic drugs. 
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Introduction 
 
Evidence suggests that the 5-HT neurones of the midbrain median raphe nucleus 
(MRN) are involved in the sleep/wake cycle.  Thus, 5-HT projections from the MRN 
have been shown to regulate activity patterns in the hippocampus involved in sleep 
(see Vertes and Kocsis, 1997) and modulate the suprachiasmatic nucleus (SCN) -
considered to contain the mammalian circadian clock-(Meyer-Bernstein and Morin, 
1999; Muscat et al., 2005).  Evidence also suggests that 5-HT neurones in the MRN 
are involved in anxiety.  Thus, 5-HT levels in MRN projection areas are reported to 
increase with anxiety (Matsuo et al., 1996; Andrews et al., 1997) and inhibition or 
ablation of MRN 5-HT neurones reduces anxiety-like behaviour in several anxiety 
models (Carli and Samanin, 1988; Andrews et al., 1994, 1997; File et al., 1996; 
Andrade et al., 2004; Dos Santos et al., 2005).   
 
It is well established that enhancing GABA neurotransmission in the brain can be 
both anxiolytic and sedative/hypnotic.  Some data indicate that anxiolysis and sleep 
are mediated, at least in part, by increased activation of GABAA receptors in the 
MRN.  Thus, intra-MRN application of GABAA receptor agonists or modulators have 
been reported to reduce anxiety-like behaviour (Gonzalez et al., 1998; Dos Santos et 
al., 2005) and induce hippocampal activity patterns associated with sleep (Li et al., 
2005).   
 
Given that MRN 5-HT neurones are implicated in both sleep/wake and anxiety 
behaviours (see above), it is possible that the effects of systemically and intra-MRN 
administered, GABAA agonists and modulators on sleep and anxiety is mediated by 
the inhibition of 5-HT neurones in the MRN.  Indeed, 5-HT-immunoreactive neurones 
in the MRN have been shown to express GABAA receptor α subunit–
immunoreactivity (Gao et al., 1993) and intra-MRN injections of GABAA agonists 
have been shown to suppress 5-HT release in MRN innervated forebrain regions (Tao 
et al., 1996; Shim et al., 1997; Glass et al., 2003).  However, to date GABAergic 
regulation of 5-HT neuronal activity in the MRN has not been directly demonstrated.   
 
Recent data suggest that anxiolysis and sedation may be mediated by GABAA 
receptors of different subunit composition.  Thus pharmacological studies indicate 
that anxiolysis is mediated by GABAA receptors containing the α3 subunit (Atack et 
al., 2005 a,b) whilst ataxia and decreased locomotion (indices of sedation) are 
mediated by GABAA receptors containing the α  subunit (Platt et al., 2002; Rowlett et 
al., 2005).  However, the brain regions mediating the anxiolytic and sedative effects 
of GABAA receptor subunit selective drugs have not to date been examined.   
 
In the present study we used in vitro single unit electrophysiological recording in a rat 
midbrain slice preparation to examine the GABAA receptor regulation of 5-HT 
neuronal activity in the MRN.  We also examined the potential modulation of the 
response to a GABAA receptor agonist by the Z hypnotic zolpidem.  Due to its 
different affinities, this drug can be used to distinguish between α1, α2/α3 and α5 
subunit containing GABAA receptors (Pritchett and Seeburg, 1990; Araujo et al., 
1999).  
 
Experimental procedures 
 
Experimental subjects 
All experiments carried out had been reviewed and approved by the University of 
Newcastle Ethical Review Panel and were in accordance with the UK Animals 
(Scientific procedures) act of 1986 and the European Community Council Directive 
of 24
th
 November 1986 (86/609/EEC).  All efforts were made to minimize any pain or 
discomfort of the animals. Male hooded Lister rats (Charles River, Kent, UK) (200-
400 g), were group housed under controlled conditions of temperature and humidity 
in a 12 h light/dark cycle (lights on 7 am).  All animals were allowed to acclimatise to 
the holding facilities for at least one week before use. 
 
Electrophysiology 
Animals were decapitated (without prior anaesthesia) between 8.30 and 10.00 am.  
The brain was quickly removed and submerged in oxygenated (95% O2-5% CO2) 
sucrose slush (composition (mM): sucrose: 200, HEPES 10, MgSO4 7, NaH2PO4 1.2, 
KCl 2.5, NaHCO3 25, CaCl2 0.5, D-glucose 10, pH 7.4) for 5 minutes.  The caudal 
portion of the brain was then mounted on a block using cyanoacrylate glue and 
submerged in oxygenated sucrose slush in the chamber of a vibrating microtome 
(Vibratome 1000, Vibratome, St.  Louis, USA).  Coronal slices of the midbrain (350 
μm thick), containing the MRN, were cut and then transferred to a Petri dish 
containing oxygenated artificial cerebrospinal fluid (aCSF) (composition (mM): NaCl 
124, MgSO4 2.4, KH2PO4 1.25, KCl 3.25, NaHCO3 26, CaCl2 2, D-glucose 10, pH 
7.4).  Slices between Bregma -7.6 and -8.0 mm (Paxinos and Watson, 1998) were 
trimmed and individual slices were placed in interface perfusion chambers and 
perfused with aCSF (0.5 ml/min) at 36˚C.  The aCSF contained the adrenoceptor 
agonist norepinephrine (NE; 30 μM) in order to evoke 5-HT neuronal firing.  
 
Extracellular recordings were made from neurones in the MRN using glass 
microelectrodes (1.5 mm OD, Clarke Electromedical, Reading, UK; 1-3 MΩ in vitro 
impedance) filled with 2 M NaCl.  Signals were amplified (x1000) with an AC 
differential preamplifier and were fed to a PC via a computer interface (1401 or 
micro1401, CED, Cambridge, UK) and collected using Spike2 software (version 4, 
CED, Cambridge, UK).  The microelectrode was advanced slowly through the slice 
(approximately 150 mm per minute) to decrease the probability of missing neurones 
with slow firing rates.  Neurones were identified on the basis of their location (in the 
MRN), basal electrophysiological characteristics of slow regular firing and an 
inhibitory response to 5-HT (25-50mM) (see Results).   
 
Following a period of recording of basal firing activity, drugs were applied via the 
perfusion medium at intervals of at least 4 minutes.  5-HT, 
4,5,6,7-Tetrahydrisoxazolo[5,4-c]pyridin-3-ol (THIP) and muscimol, were applied for 
two minutes.  Bicuculline was applied for 3 min before and 2 min during 
reapplication of the agonist.  Zolpidem was applied for 6 min before and 2 min during 
reapplication of the agonist.  Control experiments demonstrated that responses to the 
GABAA receptor agonists were quickly reversible and were not desensitised by 
repeated application, so it was possible to record more than one neurone in a slice.  
However, since bicuculline and zolpidem (>1 mM) were found to only wash off 
slowly, recordings from subsequent neurones in the same slice were delayed until at 
least 45 minutes after zolpidem and 90 minutes and after bicuculline application.  
Between 1 and 6 neurones per slice were recorded and either 1 or 2 slices from each 
animal were used.   
                                                                                                                                                                                       
Materials 
NaCl, MgSO4, KH2PO4, KCl, NaHCO3 and sucrose were purchased from BDH 
Laboratory Supplies (Dorset, UK).  Bicuculline methiodide, CaCl2, D-(+)-glucose, 
HEPES, muscimol, (±)-norepinephrine, 5-HT hydrochloride were purchased from 
Sigma.  THIP hydrochloride and zolpidem were purchased from Tocris. Stock 
solutions (10 mM) of 5-HT, muscimol and THIP were made in aCSF.  A 1 mM stock 
solution of zolpidem was made in dimethyl sulfoxide (DMSO) (maximum final 
DMSO concentration 0.5%). 
 
Data analysis and statistics 
Electrophysiological data were analysed offline from the firing rate data collected on 
Spike 2.  Basal firing was determined in a 120 s period at the start of the recording 
and is expressed in Hz.  Inhibitory responses to 5-HT and the GABAA receptor 
agonists were determined as the firing rate in a 120s period covering the maximum 
change in baseline and expressed as a percentage change (decrease) relative to the 
firing rate in the 120s immediately before the application of the drug.  A change in 
firing rate of 5% or more over the period of application of the drug was considered to 
be a ‘response’.  The effect of GABAA receptor modulators was assessed by 
comparison of the response to the agonist in the absence of and in the presence of the 
modulator.  An increase in the response by more than 10% was considered to be an 
‘enhancement’. Data presented are individual examples or the mean ± SEM.  Within 
neurone differences were analysed by paired t-test, Wilcoxon signed ranks test or one-
way repeated measures ANOVA and between group differences were analysed by 
unpaired t-test or two-way repeated measures ANOVA.   
 
Results 
 
Firing activity of MRN neurones 
In the presence of the adrenoceptor agonist, norepinephrine (30 mM), 112 slow firing 
(0.29 -4.63 Hz) neurones were recorded in the MRN.  All neurones were tested with 
5-HT (25-50 mM) and those which showed an inhibitory response to 5-HT were 
considered to be 5-HT neurones (n = 101).  The basal firing rate of these 5-HT 
neurones ranged from 0.29 – 3.16 Hz (mean basal firing rate; 1.09 ± 0.07 Hz, n = 
101). Of these 101 neurones 99 showed an inhibitory response to 25 mM 5-HT (mean 
inhibition 55.6 ± 3.2 %; range 9.7 to 100 %).  The firing activity of the 2 neurones 
insensitive to 25mM 5-HT, was inhibited by 50 mM 5-HT.   
 
Of the remaining 11 neurones, 8 neurones were excited and 3 were insensitive to 
5-HT.  The basal firing rate of the non-5-HT neurones ranged from 0.93 – 4.63 Hz 
(mean basal firing rate; 1.97 ± 0.33 Hz, n = 11).  
 
Response of MRN 5-HT neurones to GABAA receptor agonists 
The firing activity of 5-HT neurones in the MRN (56/59) was inhibited by the 
GABAA receptor agonist THIP (10-25 mM) (Fig. 1A).  Of these 56 neurones 49 
showed an inhibitory response to THIP (10 mM) (mean inhibition 20.2 ± 2.7 %, n = 
49; range 5.1 to 100 %).  The firing activity of those neurones which were insensitive 
to 10 mM THIP, decreased, when tested with 25 mM THIP (n = 7).  5-HT neurones (n 
= 7) tested with increasing concentrations of THIP (10, 25, 50 mM) showed a 
concentration dependent inhibitory response (Fig. 1B).  Repeated applications of 
THIP produced inhibitory responses that differed by less than 10% (range -8.1 to 
9.4%, n =10).  There was no statistical difference between the responses to the first 
and second application (mean difference 1.4 ± 2.1 %, n = 10; p = 0.53, paired t-test). 
 
The GABAA receptor agonist muscimol (1-10 mM) inhibited the firing rate of all 
neurones tested (n = 15, Fig. 1C).  Of these 15 neurones, 13 showed an inhibitory 
response to muscimol (3 mM) (mean inhibition 56.7 ± 10.1 %, n = 13; range 9.3 to 
100 %).  The two neurones not inhibited by 3 mM muscimol were inhibited by 10 mM 
muscimol.  5-HT neurones (n = 7) tested with increasing concentrations of muscimol 
(1, 3, 10 mM) showed a concentration dependent inhibitory response (Fig. 1D).  
Interestingly, there was a strong positive correlation between the responses to 5-HT 
(25 mM) and muscimol (3 mM) (n = 13, Pearson correlation = 0.83, p = 0.001) (Fig. 
2). 
 
The inhibitory responses to both THIP (50 mM) and muscimol (3 mM) were blocked 
by the GABAA receptor antagonist bicuculline (50 mM) (Fig. 3).  Thus the mean 
inhibitory response to THIP in the absence of bicuculline was 82.4 ± 7.4 % compared 
to just 6.1 ± 5.6 % (n = 9) in the presence of the antagonist (p < 0.001, paired t-test, 
Fig. 3A).  Similarly, the mean inhibitory response to muscimol in the absence of 
bicuculline was 49.5 ± 16.2 % (n = 6) compared to a response of -2.9 ± 1.5 % in the 
presence of bicuculline (p < 0.05, Wilcoxon signed ranks test, Fig. 3B,C).   
 
The GABAA receptor antagonist, bicuculline alone increased the basal firing rate of 
the 5-HT neurones (see Fig. 3C).  In the presence of bicuculline (50 mM) alone, the 
basal firing rate increased by 36.0 ± 6.2 % (0.91 ± 0.11 to 1.23 ± 0.15 Hz, n = 15; p < 
0.001, paired t-test).  
 
Modulation of GABAA receptor response by zolpidem 
 
The effect of the Z hypnotic zolpidem (0.02 – 5 mM) on a submaximal response to 
THIP (10 – 25 mM) was examined.  Zolpidem 0.02 mM enhanced the response to 
THIP in 1/11 neurones tested (9%).  The remaining 10 neurones showed no consistent 
change in the magnitude of the response to THIP.  The mean inhibitory response to 
THIP was not significantly altered by 0.02 mM zolpidem (mean inhibitory response to 
THIP 32.2 ± 7.5 vs 35.6 ± 8.7 %, n = 11; p = 0.23, paired t-test; Fig. 4A,B).  A 
concentration of 0.2 mM zolpidem enhanced the response to THIP in 10 of 15 
neurones tested (67%) and had no effect on the response in the remaining 5 neurones.  
In this group of 15 neurones the mean response to THIP was significantly enhanced 
by zolpidem (0.2 mM) (mean inhibitory response to THIP 26.6 ± 4.2 vs 43.2 ± 6.8 %; 
p < 0.05, paired t-test; Fig. 4A,C).  Application of 1 mM zolpidem enhanced the 
response to THIP in all 9 neurones tested, which included the 5 neurones which failed 
to show a response to 0.2 mM zolpidem.  Analysis of the group data showed a 
significant effect of zolpidem at this concentration (mean inhibitory response to THIP 
17.9 ± 2.0 vs 52.6 ± 7.5 %; p < 0.001, paired t-test, Fig. 4D).  The highest 
concentration of zolpidem (5 mM) enhanced the response to THIP in all 5 neurones 
tested.  Again the mean response to THIP was significantly enhanced by zolpidem 
(mean inhibitory response to THIP18.2 ± 2.9 vs 67.4 ± 10.2 %; (n = 5; p < 0.05, 
paired t-test, Fig. 4E).   
 
Zolpidem alone had no effect on the basal firing rate of the 5-HT neurones at any of 
the concentrations tested (0.02 mM, n = 11; 0.2 mM, n = 15; 1 mM, n = 9; 5 mM, n = 5; 
paired t-test). 
 
Discussion 
 
Using extracellular electrophysiology in the in vitro slice preparation we examined 
the regulation of 5-HT neuronal activity in the MRN by GABAA receptors. 
Furthermore, we assessed the modulation of the neuronal responses to GABAA 
receptor activation by a Z hypnotic, which has differential affinity for GABAA 
receptors containing α1, α2/α3 and α5 subunits. 
 
Identity of neurones recorded 
The MRN neurones recorded in this study fired slowly and regularly in the presence 
of the adrenoceptor agonist, noradrenaline.  The vast majority of these neurones was 
inhibited by 5-HT.  We have previously shown that the 5-HT inhibition of MRN 
neurones is greatly attenuated by WAY100635 (Judge and Gartside, 2005), indicating 
mediation by 5-HT1A receptors.  As it has been shown that only 5-HT-containing 
neurones in the MRN are hyperpolarized by a 5-HT1A receptor agonist (Beck et al., 
2004), we can be confident that the neurones inhibited by 5-HT in the present study 
are 5-HT-containing.   
 
GABAA receptor regulation 
The selective GABAA receptor agonists THIP and muscimol (Kemp et al., 1986; 
Krogsgaard-Larsen and Falch, 1981) inhibited the firing activity of 5-HT neurones in 
the MRN.  Although THIP has been reported to show a preference for δ containing 
GABAA receptors (Krogsgaard-Larsen et al., 2002), it is unlikely that at the 
concentrations used in the present study such a preference was demonstrated.  The 
inhibitory responses were concentration dependent and attenuated by the selective 
GABAA receptor antagonist bicuculline (Bowery et al., 1984).  These data indicate 
that MRN 5-HT neurones are inhibited by GABAA receptor activation.  This is 
consistent with the indirect evidence from microdialysis studies in which it has been 
shown that  intra-MRN injections of GABAA agonists suppress 5-HT release in the 
hippocampus and SCN (Shim et al., 1997; Glass et al., 2003), whilst GABAA 
antagonists stimulate 5-HT release in SCN (Glass et al., 2003). 
 
It is of note that we found that the responses of the MRN 5-HT neurones to 5-HT and 
muscimol were positively correlated.  This may simply be due to the baseline 
membrane potential of the neurone or alternatively it could indicate that the 
expression or function of GABAA and 5-HT1A receptors on MRN 5-HT neurones are 
somehow linked.  However, the response to THIP was not correlated with the 
response to 5-HT.  It is unclear why there is this discrepancy.   
 
Modulation of GABAA receptors and subunit composition  
We found that the inhibitory responses to THIP were enhanced by the Z hypnotic 
zolpidem.  This drugs acts at the benzodiazepine binding site to enhance transmission 
(Arbilla et al., 1986).  In the present study we used the Z hypnotic zolpidem to 
examine the α subunit composition of the GABAA receptors on MRN 5-HT neurones.  
This drug has Ki values of 0.02, 0.4 and 5 mM for α1, α2/α3 and α5 -containing 
GABAA receptors, respectively (Pritchett and Seeburg, 1990; Araujo et al., 1999) and 
hence can be used to make inferences about the α-subunit composition of the 
receptors.  We found that 0.2 mM, zolpidem enhanced the response to THIP in two-
thirds of MRN 5-HT neurones tested, whilst all showed enhancement at 1 mM.  These 
concentrations are one twenty-fifth and one fifth, respectively of the Ki for α5 -
containing GABAA receptors. Therefore we conclude that the GABAA receptors on 
MRN 5-HT neurones do not contain the α5 subunit.  Since these concentrations of 
zolpidem (0.2 mM and 1 mM) are one half and 2.5 times the reported Ki for α2/α3 -
containing GABAA receptors, the data are consistent with the majority of 5-HT 
neurones in the MRN possessing α2/α3 -containing GABAA receptors.  Finally we 
observed clear enhancement of the THIP response in 1 neurone (9%) after the lowest 
concentration of zolpidem (0.02 mM) was applied.  This is equal to the Ki for α1, -
containing GABAA receptors and suggests that a small proportion of MRN 5-HT 
neurones possess α1-containing GABAA receptors.  Taken together our functional data 
are entirely consistent with the immunocytochemical evidence that the majority of 
5-HT-immunoreactive neurones in the raphe nuclei are immunoreactive for the α3 
GABAA receptor subunit with only a small minority immunoreactive for the α1 and α2 
GABAA receptor subunit (Gao et al., 1993; Rodriguez-Pallares et al., 2001). 
 
Tonic GABAergic regulation in the slice preparation 
Here we found that application of the GABAA antagonist bicuculline increased the 
basal firing rate of 5-HT neurones in the MRN suggesting that the MRN is under 
tonic GABAergic tone in the slice preparation.  We have also recently shown that 
5-HT neurones in the dorsal raphe nucleus (DRN) are inhibited by GABAA receptor 
activation (Judge et al., 2004) but in contrast to the present data, we found no effect of 
GABAA antagonists on 5-HT neuronal firing in the DRN.  The effect of bicuculline in 
the MRN suggests that MRN 5-HT neurones are innervated by a population of 
GABAergic neurones which are present in the midbrain slice.  A few GABAergic 
neurones are located in the midline of the DRN and MRN amongst the 5-HT 
neurones, but a much greater number are found in the lateral wings of the DRN and 
adjacent areas such as the ventral tegmental nucleus and periaqueductal grey area 
(Serrats et al., 2003; Day et al., 2004).  Consistent with our data showing GABAergic 
tone, recent in vivo studies have shown that GABAA receptor antagonists increase 
5-HT release in MRN innervated areas (Glass et al., 2003; Li et al., 2005).  In other 
brain regions GABAergic tone is mediated by α4 containing GABAA receptors (Jia et 
al., 2005; Mangan et al., 2005).  As application of zolpidem alone did not decrease 
basal firing rate at even the highest concentration (5mM), it is probable that 
GABAergic tone in the MRN is also mediated by this receptor subtype. 
 
Implications for the actions of anxiolytic and sedative drugs 
 
It has been shown previously that application of benzodiazepines directly into the 
MRN is anxiolytic (Gonzalez et al., 1998).  Given that anxiolysis is reportedly 
mediated by α3 subunit–containing GABAA receptors (Atack et al., 2005 a,b), our data 
showing enhancement at α2/α3 subunit–selective concentrations, indicate that 5-HT 
neurones in the MRN may be involved in the action of systemically applied anxiolytic 
drugs.  In contrast, sedation is reported to be mediated by α  subunit–containing 
GABAA receptors (Crestani et al., 2000; Rowlett et al., 2005).  Our data indicate that 
only a small proportion of the 5-HT neurones in the MRN possess this particular type 
of GABAA receptor and we conclude that sedation is not likely to be mediated by 
inhibition of 5-HT neurones in the MRN.   
 
Summary 
 
We have shown that the firing activity of 5-HT neurones in the MRN is regulated by 
GABAA receptors.  Taken together with immunocytochemical data (Gao et al., 1993; 
Rodriguez-Pallares et al., 2001), our data also indicate that the majority of the 
GABAA receptors contain α3 subunits which have been shown to mediate anxiolytic 
effects of GABAA receptor modulators.  Thus GABAergic inhibition of MRN 5-HT 
neurones may be involved in the action of anxiolytic drugs.   
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 Figure 1.  Inhibitory responses of 5-HT neurones in the MRN to GABAA receptor 
agonists.  (A) Example of a recording showing responses to 5-HT (25 μM) and 
increasing concentrations of THIP of an individual neurone.  THIP (10, 25 and 50 
μM) was applied for periods of 2 min as indicated by the bars.  Note that the 
recording has not been corrected for the perfusion lag (approximately 2 min).  Basal 
activity was recorded in the continuous presence of 30 mM NE. (B) Concentration-
response relationship for inhibitory responses to THIP in MRN neurones (n = 7).  (C) 
Example of a recording from an individual neurone showing responses to 5-HT (50 
μM) and increasing concentrations of muscimol (1, 3 and 10 μM) applied for periods 
of 2 min as indicated by bars.  (D) Concentration-response relationship for inhibitory 
responses to muscimol in MRN neurones (n = 7).  Data shown are mean ± SEM. 
 
 Figure 2.  Correlation between inhibitory responses of individual MRN 5-HT 
neurones to 5-HT (25 μM) and muscimol (3 μM).  The regression line is also shown.  
 Figure 3.  Inhibitory responses of MRN 5-HT neurones to (A) THIP (50 μM) and (B) 
muscimol (3 μM) in the absence and presence of the GABAA receptor antagonist 
bicuculline (50 μM).  The responses from the same neurones are joined by a line.  (C)  
Example of a recording showing responses of an individual neurone to muscimol (3 
μM) in the absence and presence of bicuculline.  Bicuculline was applied for 3 min 
before and 2 min during reapplication of muscimol as indicated by the bars. 
Note that the basal firing rate increased following the application of bicuculline alone. 
 
 Figure 4.  Inhibitory responses of MRN 5-HT neurones to THIP (10-25 μM) in the 
absence and presence of the Z hypnotic zolpidem.  (A) Example of a recording 
showing responses of an individual neurone to THIP (25 μM) in the absence and 
presence of increasing concentrations of zolpidem (0.02 and 0.2 μM).  Zolpidem was 
applied for 6 min before and 2 min during reapplication of THIP as indicated by the 
bars. (B-E) Inhibitory responses of individual MRN 5-HT neurones to THIP (10-25 
μM) in the absence and presence of (B) 0.02 μM, (C) 0.2 μM, (D) 1 μM and (E) 5 μM 
zolpidem.  The responses from the same neurones are joined by a line.   
